%0 Journal Article
%T Determinants of adherence to treatment in patients with ophthalmic conditions.
%A Muñoz-Villegas P
%A Martínez-Bautista H
%A Olvera-Montaño O
%J Expert Rev Clin Pharmacol
%V 16
%N 12
%D 2023 Jul-Dec
%M 37978952
%F 4.108
%R 10.1080/17512433.2023.2279740
%X <B>UNASSIGNED: </B>The objective of this study was to identify and determine factors associated with patients' ophthalmic adherence in common ocular conditions from randomized clinical trials (RCT).<BR><B>UNASSIGNED: </B>A univariate analysis with proportions, a bivariate analysis using polychoric correlations, and logistic regression (LR) models were used. The collected dataset was made up of records from RCT. Using three validated LR models, factors were identified and ranked based on their adjusted odds ratio and their statistical significance to adherence.<BR><B>UNASSIGNED: </B>A total of 1,087 valid patients were included in this analysis, of which 88.96% presented adherence. All models were calibrated, had a good performance, were well specified and cost-effective using the Hosmer-Lemeshow test, metrics for class imbalance, link test approach and Akaike's criteriums, respectively.<BR><B>UNASSIGNED: </B>We identified as determinants for encouraging good ophthalmic adherence the adverse events presented, duration of the study, female sex, and older age; other determinants such as medical condition, protocol treatment, type of treatment and disease are all risk factors for adherence. Improvements in ophthalmic adherence may be achieved by focused attention to young male patients with chronic degenerative diseases such as glaucoma or ocular hypertension (especially those who need combination therapy) and developing medications with reduced side effects.